Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.35
+0.05 (0.15%)
Oct 8, 2026, 12:58 PM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 720.14 million as of October 9, 2026. It is the 36,248th most valuable company in the world and the 2,175th biggest in Taiwan. Its market cap has decreased by 1.91% in one year.
Market Cap
720.14M
Enterprise Value
626.66M
Revenue
379.21M
Global Rank
Country Rank
#2,175 Taiwan
PE Ratio
104.15
ChartMarket Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 720.14M, a decrease of -57.61%. That is a compound annual growth rate of -8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 720.14M | 10.61% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.96B |
| DIVA Laboratories | 1.83B |
| Genetics Generation Advancement | 1.09B |
| Puriblood Medical | 1.03B |
| Kim Forest Enterprise | 775.93M |
| TFBS Bioscience | 674.33M |
| Welgene Biotech | 395.01M |
| Pharmigene | 352.75M |